Drugs / sodium picosulfate, magnesium oxide and citric acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02386449 | Feb → Dec 2015 | — | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium picosulfate, magnesium oxide and citric acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02386449 ↗ |
| Known as | Picoprep | “sodium picosulfate, magnesium oxide and citric acid (Picoprep®)” NCT02386449 ↗ |
| Route | Oral | “Oral Sodium Picosulfate (PicoPrep®) Versus Oral Mannitol and Bisacodyl” NCT02386449 ↗ |